InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,468.98
(
0.42%
)
Post# of 47548
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

zebra4o1

Send PM Follow Ignore
Followers 4
Posts 603
Boards Moderated 0
Alias Born 03/05/2004

zebra4o1

Re: Aiming4 post# 11233

Monday, 10/15/2007 2:05:24 AM

Monday, October 15, 2007 2:05:24 AM

Post# of 47548
Aiming,

I don't see any permanent damage to the ampakine platform or the blue sky potential of ampakines. And these junior biotechs like Cortex have nine lives. CX717 maybe be damaged goods, but there will be other compounds (eventually). And I believe money spent on CX717 toxicology was well spent. The safety of the ampakine platform had to be defended at all costs.

An ampakine could still be the next blockbuster drug for Alzheimer’s. An ampakine could still be the next blockbuster drug in schizophrenia. And let's not forget about depression. Seems like ampakines are being studied in universities all over the world now. Who knows when the next RD-type indication will come along? And aren't Pfizer and others desperate for new products?

From a cynical trading perspective, it doesn't really matter if none of this potential is ever realized. All we need is for something to happen which gets investors dreaming about the possibilities (then we have to remember to sell).

I agree that things are somewhat different this time, bleaker in some respects. But things are better in other respects. Cortex has better compounds, better chemistry, and they have more clinical data in humans that ampakines actually do something.

Dr. Tracy has said many times that ampakines are the most exciting platform in CNS. Has that changed just because the FDA is cracking down on ADHD drugs?

I'm not claiming that Cortex will got to $50, or that there is no risk in buying now. I just believe the risk/reward of buying Cortex at 80 cents is pretty good.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RSPI News
More RSPI News
InvestorsHub NewsWire

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM

Start posting your company's news
Only $200 per official company press release!